Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438).
Source:http://linkedlifedata.com/resource/pubmed/id/18256325
Blood
2008
Apr
15
111
8
4048-54
